Urinary excretion and metabolism of the α-pyrrolidinophenone designer drug 1-phenyl-2-(pyrrolidin-1-yl)octan-1-one (PV9) in humans

Metabolism of the designer drug α-pyrrolidinobutiophenone (α-PBP) in humans: Identification and quantification of the phase I metabolites in urine

(2015) Shuntaro Matsuta et al.   FORENSIC SCIENCE INTERNATIONAL

New Designer Drugs (Synthetic Cannabinoids and Synthetic Cathinones): Review of Literature

(2014) Olivier Cottencin et al.   CURRENT PHARMACEUTICAL DESIGN

Postmortem distribution of PV9, a new cathinone derivative, in human solid tissues in a fatal poisoning case

(2014) Koutaro Hasegawa et al.   Forensic Toxicology

Determination of new pyrrolidino cathinone derivatives, PVT, F-PVP, MPHP, PV8, PV9 and F-PV9, in human blood by MALDI-Q-TOF mass spectrometry

(2014) Kayoko Minakata et al.   Forensic Toxicology

Identification and quantitation of a new cathinone designer drug PV9 in an “aroma liquid” product, antemortem whole blood and urine specimens, and a postmortem whole blood specimen in a fatal poisoning case

(2014) Koutaro Hasegawa et al.   Forensic Toxicology

Postmortem distribution of α-pyrrolidinovalerophenone and its metabolite in body fluids and solid tissues in a fatal poisoning case measured by LC–MS–MS with the standard addition method

(2014) Koutaro Hasegawa et al.   Forensic Toxicology

Chemical analysis of a benzofuran derivative, 2-(2-ethylaminopropyl)benzofuran (2-EAPB), eight synthetic cannabinoids, five cathinone derivatives, and five other designer drugs newly detected in illegal products

(2014) Nahoko Uchiyama et al.   Forensic Toxicology

New recreational drug 1-phenyl-2-(1-pyrrolidinyl)-1-pentanone (alpha-PVP) activates central nervous system via dopaminergic neuron

(2014) Asuka Kaizaki et al.   JOURNAL OF TOXICOLOGICAL SCIENCES

Designer psychostimulants: Pharmacology and differences

(2014) Leslie Iversen et al.   NEUROPHARMACOLOGY

Pharmacology of novel synthetic stimulants structurally related to the “bath salts” constituent 3,4-methylenedioxypyrovalerone (MDPV)

(2014) Julie A. Marusich et al.   NEUROPHARMACOLOGY

In silico and in vitro metabolism studies support identification of designer drugs in human urine by liquid chromatography/quadrupole-time-of-flight mass spectrometry

(2013) Elli Tyrkkö et al.   ANALYTICAL AND BIOANALYTICAL CHEMISTRY

Khat and synthetic cathinones: a review

(2013) Maria João Valente et al.   ARCHIVES OF TOXICOLOGY

Thein vivoandin vitrometabolism and the detectability in urine of 3’,4’-methylenedioxy-alpha-pyrrolidinobutyrophenone (MDPBP), a new pyrrolidinophenone-type designer drug, studied by GC-MS and LC-MSn

(2013) Markus R. Meyer et al.   Drug Testing and Analysis

Metabolism of the newly encountered designer drug α-pyrrolidinovalerophenone in humans: identification and quantitation of urinary metabolites

(2013) Noriaki Shima et al.   Forensic Toxicology

Recently abused synthetic cathinones, α-pyrrolidinophenone derivatives: a review of their pharmacology, acute toxicity, and metabolism

(2013) Kei Zaitsu et al.   Forensic Toxicology

Time-course profile of urinary excretion of intravenously administered α-pyrrolidinovalerophenone and α-pyrrolidinobutiophenone in a human

(2013) Akira Namera et al.   Forensic Toxicology

A fatal case of 3,4-methylenedioxypyrovalerone poisoning: coexistence of α-pyrrolidinobutiophenone and α-pyrrolidinovalerophenone in blood and/or hair

(2013) Akira Namera et al.   Forensic Toxicology

SPME–GC–MS analysis of α-pyrrolidinovaleorophenone in blood in a fatal poisoning case

(2013) Takeshi Saito et al.   Forensic Toxicology

Postmortem Tissue Distribution of MDPV Following Lethal Intoxication by "Bath Salts"

(2013) J. F. Wyman et al.   JOURNAL OF ANALYTICAL TOXICOLOGY

Pharmacological characterization of designer cathinonesin vitro

(2012) LD Simmler et al.   BRITISH JOURNAL OF PHARMACOLOGY

Urinary excretion and metabolism of the newly encountered designer drug 3,4-dimethylmethcathinone in humans

(2012) N. Shima et al.   Forensic Toxicology

Powerful Cocaine-Like Actions of 3,4-Methylenedioxypyrovalerone (MDPV), a Principal Constituent of Psychoactive ‘Bath Salts’ Products

(2012) Michael H Baumann et al.   NEUROPSYCHOPHARMACOLOGY

Acute poisoning involving the pyrrolidinophenone-type designer drug 4′-methyl-alpha-pyrrolidinohexanophenone (MPHP)

(2011) Christoph Sauer et al.   FORENSIC SCIENCE INTERNATIONAL

Beta-keto amphetamines: studies on the metabolism of the designer drug mephedrone and toxicological detection of mephedrone, butylone, and methylone in urine using gas chromatography–mass spectrometry

(2010) Markus R. Meyer et al.   ANALYTICAL AND BIOANALYTICAL CHEMISTRY

Studies on the metabolism of the α-pyrrolidinophenone designer drug methylenedioxy-pyrovalerone (MDPV) in rat and human urine and human liver microsomes using GC-MS and LC-high-resolution MS and its detectability in urine by GC-MS

(2010) Markus R. Meyer et al.   JOURNAL OF MASS SPECTROMETRY

Toxicological determination and in vitro metabolism of the designer drug methylenedioxypyrovalerone (MPDV) by gas chromatography/mass spectrometry and liquid chromatography/quadrupole time-of-flight mass spectrometry

(2010) Sabina Strano-Rossi et al.   RAPID COMMUNICATIONS IN MASS SPECTROMETRY

Determination of the metabolites of the new designer drugs bk-MBDB and bk-MDEA in human urine

(2009) Kei Zaitsu et al.   FORENSIC SCIENCE INTERNATIONAL

New designer drug α‐pyrrolidinovalerophenone (PVP): studies on its metabolism and toxicological detection in rat urine using gas chromatographic/mass spectrometric techniques

(2009) Christoph Sauer et al.   JOURNAL OF MASS SPECTROMETRY